Drug Regulation and Pricing — Can Regulators Influence Affordability?

N Engl J Med 2016; 374:1807-1809May 12, 2016DOI: 10.1056/NEJMp1601294
Authors: Hans-Georg Eichler, M.D., Hugo Hurts, M.Sc., Karl Broich, M.D., and Guido Rasi, M.D.
“Public debate in the 1990s over drugs’ clinical toxicity has given way to concerns about their financial toxicity. Although drug regulators aren’t supposed to be concerned with pricing, they’ve been drawn into an acrimonious debate over the cost of medicines.”
Find article here.